Order Article Reprints

Zhang D, Shah NJ, Cook M, Blackburn M, Serzan MT, Advani S, Potosky AL, Madhavan S, Belouali A, Atkins MB, et al. Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109. Cancers. 2022; 14(18):4525. https://doi.org/10.3390/cancers14184525

Zhang, Dongyu, Neil J. Shah, Michael Cook, Matthew Blackburn, Michael T. Serzan, Shailesh Advani, Arnold L. Potosky, Subha Madhavan, Anas Belouali, Michael B. Atkins, and et al. 2022. "Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109" Cancers 14, no. 18: 4525. https://doi.org/10.3390/cancers14184525

Zhang, D., Shah, N. J., Cook, M., Blackburn, M., Serzan, M. T., Advani, S., Potosky, A. L., Madhavan, S., Belouali, A., Atkins, M. B., & Braithwaite, D. (2022). Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109. Cancers, 14(18), 4525. https://doi.org/10.3390/cancers14184525